PhD candidate on a cell therapy for cornea regeneration at the MERLN Institute for Technology-Inspired Regenerative Medicine, Maastricht University

Fixed-term contract: 4 years.

It is a temporary employment for 4 years. The first year will be a probation period, after a positive assessment the position will be extended for another 3 years, which happens in the vast majority of cases.

Your salary would be € 2.434,- gross per month in the first year up to € 3.111,- gross per month in the fourth year according to the PhD-candidate salary scale. An 8% holiday and an 8.3% year-end allowance is also provided. Each year an evaluation will take place.

The terms of employment of Maastricht University are set out in the Collective Labour Agreement of Dutch Universities (CAO). Furthermore, local UM provisions also apply. For more information look at the website www.maastrichtuniversity.nl  > About UM > Working at UM .

The successful candidate will have a cross-disciplinary supervision team comprising Dr Mor Dickman (University Eye Clinic Maastricht) and Dr Vanessa LaPointe (MERLN Institute for Technology-Inspired Regenerative Medicine). They will collaborate closely with the team of Dr Jo Zhou (Radboud UMC, Nijmegen).

The candidate will mainly perform this research in the laboratory of Dr LaPointe at the MERLN Institute at Maastricht University. At MERLN, we are a collaborative, international, and interdisciplinary group with diverse expertise, including biomaterials science, chemistry, tissue engineering, and (stem) cell biology. We share newly renovated laboratory facilities with modern equipment. We have a long history as leaders in the field of tissue engineering and are particularly well-known for our orientation towards translational research.

The University Eye Clinic/Maastricht University Medical Center+ is one the largest academic departments of ophthalmology in Europe. The department is built on a strong foundation of medical education, research, and clinical care. Our clinicians provide care ranging from the routine to the very complex. Scientific work is focused on corneal diseases, cataract, and glaucoma, and is driven by a mission to understand and discover the basis for these conditions, and to develop treatments with a direct impact for patients and society.